Baird Financial Group Inc. Has $23.55 Million Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Baird Financial Group Inc. raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 23.4% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 45,118 shares of the medical equipment provider's stock after acquiring an additional 8,551 shares during the quarter. Baird Financial Group Inc.'s holdings in Intuitive Surgical were worth $23,550,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Bennett Selby Investments LP increased its position in shares of Intuitive Surgical by 3.9% in the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock worth $234,000 after purchasing an additional 17 shares during the last quarter. Onefund LLC increased its holdings in shares of Intuitive Surgical by 1.9% in the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock worth $494,000 after buying an additional 18 shares during the last quarter. LVW Advisors LLC raised its position in shares of Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock valued at $756,000 after buying an additional 19 shares in the last quarter. Wesbanco Bank Inc. lifted its holdings in shares of Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock worth $635,000 after acquiring an additional 19 shares during the last quarter. Finally, Journey Strategic Wealth LLC grew its position in Intuitive Surgical by 1.9% in the fourth quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider's stock worth $542,000 after acquiring an additional 19 shares in the last quarter. Institutional investors own 83.64% of the company's stock.

Insider Activity at Intuitive Surgical

In related news, EVP Robert Desantis sold 11,545 shares of the company's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now owns 5,224 shares of the company's stock, valued at approximately $2,607,925.28. This represents a 68.85 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Jamie Samath sold 269 shares of the business's stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the transaction, the chief financial officer now owns 3,282 shares in the company, valued at $1,936,380. The trade was a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 33,313 shares of company stock worth $17,229,143. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Trading Up 0.5 %

Shares of ISRG stock opened at $531.82 on Tuesday. Intuitive Surgical, Inc. has a 12 month low of $379.67 and a 12 month high of $616.00. The stock has a market cap of $190.61 billion, a P/E ratio of 82.97, a P/E/G ratio of 5.85 and a beta of 1.70. The company has a 50 day simple moving average of $503.33 and a two-hundred day simple moving average of $534.46.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The company had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. During the same period last year, the firm earned $1.50 EPS. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts have issued reports on ISRG shares. Bernstein Bank lifted their price target on Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a research note on Monday, January 27th. Erste Group Bank cut shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Monday, March 17th. Jefferies Financial Group upped their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Royal Bank of Canada decreased their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Finally, Piper Sandler dropped their price objective on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a report on Wednesday, April 23rd. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $598.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.